Posted on Leave a comment

Acurx Pharmaceuticals Completes $4.0 Million Equity Offering That Accelerates Mission To Bring A Front-Line C. difficile Treatment To Market ($ACXP)

Acurx Pharmaceuticals (NasdaqCM: ACXP) announced completing a stock purchase agreement with a single institutional investor in May 2023, offering a mix of shares and warrants to provide ACXP with $4.0 million before fees and offering expenses at $3 per share. Ironically, shares traded lower on the deal’s announcement. But that’s not necessarily bad news. The […]

Posted on Leave a comment

Deep Vein Thrombosis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Bayer, Pfizer, Biocad, MinaPharm Pharmaceuticals, LEO Pharma, Agen

DelveInsight’s “Deep Vein Thrombosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Deep Vein Thrombosis. DelveInsight’s “Deep Vein Thrombosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Deep Vein Thrombosis, historical and forecasted epidemiology as well as the Deep Vein Thrombosis market trends in the […]

Posted on Leave a comment

Synovial Sarcoma Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, and Growth Prospects | Takara Bio, C4 Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Synovial Sarcoma pipeline constitutes 14+ key companies continuously working towards developing 14+ Synovial Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Synovial Sarcoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline […]

Posted on Leave a comment

Cystinosis Market expected to rise, AVROBIO, Nacuity Pharmaceuticals, expected to drive market

Cystinosis Market DelveInsight’s “Cystinosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Cystinosis, historical and forecasted epidemiology as well as the Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cystinosis market growth is driven by factors like increase in the […]

Posted on Leave a comment

Chronic Insomnia Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approval, and Forecast by DelveInsight | Vanda Pharmaceutical, Janssen, Taisho Pharma, Neurim Pharma, Imbrium

Chronic Insomnia Market (Albany, USA) DelveInsight’s “Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.   To Know in detail about […]

Posted on Leave a comment

Hemophilia A Therapeutic Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals, Breakthroughs, Clinical and Non-Clinical Trials, Emerging Therapies, and Treatment by DelveInsight

Hemophilia A Therapeutic Pipeline As per DelveInsight’s assessment, globally, Hemophilia A pipeline constitutes 40+ key companies continuously working towards developing 40+ Hemophilia A treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. (Las Vegas, Nevada, United States) “Hemophilia A Pipeline Insight, 2023” report by DelveInsight outlines comprehensive […]

Posted on Leave a comment

Small Cell Lung Cancer Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Carrick Therapeutics, Xencor, Aileron Therapeutics, Ipsen

Small Cell Lung Cancer Pipeline As per DelveInsight’s assessment, globally, Small Cell Lung Cancer pipeline constitutes 100+ key companies continuously working towards developing 100+ Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. (Las Vegas, Nevada, United States) “Small Cell Lung Cancer Pipeline […]

Posted on Leave a comment

Orlando Gym Launches Innovative Youth Personal Training Program: Teaching Kids and Teens to Master Their Fitness Journey.

Darwin Fitness, an independent private training gym located at 110 N Orlando Ave Suite 5 in Maitland, FL, known for its specialized fitness offers, is excited to announce its newly structured program focusing on teaching versus coaching for children and teens. Since 2012, their in-house team of certified personal trainers has been dedicated to understanding […]

Posted on Leave a comment

Developmental and Epileptic Encephalopathy Market to Witness Growth by 2032, Estimates DelveInsight | Jazz Pharmaceuticals, Biocodex, Zogenix, Lundbeck, Marinus Pharmaceuticals, Novartis, Takeda

Developmental and Epileptic Encephalopathy Market (New York, USA) DelveInsight’s Developmental and Epileptic Encephalopathy Market Insights report includes a comprehensive understanding of current treatment practices, developmental and epileptic encephalopathy emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, […]

Posted on Leave a comment

Advanced Renal Cell Carcinoma Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies by DelveInsight | AstraZeneca, Ipsen, Novartis, Merck Sharp & Dohme Corp., Pfizer, Bayer

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Advanced Renal Cell Carcinoma Pipeline report embraces in-depth commercial […]